{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:48:34Z","timestamp":1783205314731,"version":"3.54.6"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Janssen Biologics B.V."},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim of this study was to investigate the reliability, validity, and sensitivity to change of a novel MRI scoring system in early peripheral SpA (pSpA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>MRI of the pelvis and lower extremities was performed before initiation of the TNF inhibitor golimumab in 56 patients and repeated in 46 patients who achieved sustained clinical remission after 24, 36 or 48\u2009weeks. Three readers applied a semi-quantitative MRI scoring system for lower-extremity joint and entheseal inflammation. Four lesion types were assessed: entheseal osteitis, entheseal soft-tissue inflammation, joint osteitis, and joint synovitis\/effusion. MRI response was defined as a decrease in MRI lower-extremity inflammation index (sum of scores from 75 sites, each scored 0\u20133) above the smallest detectable change (SDC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At follow-up, the MRI index decreased in 34 of 46 patients (74%), and 15 (33%) patients achieved MRI response, i.e. a decrease above SDC of 2.8. When restricting the analysis to patients with clinical involvement of lower-extremity sites that were assessed by MRI, 13 of 28 (46%) achieved MRI response. Interreader reliability was very good, with an average-measure intraclass correlation coefficient of 0.92 (95% CI: 0.85\u20130.95) for status scores and 0.89 (0.80\u20130.94) for change in scores. The MRI index correlated with other measures of disease activity, including CRP [Spearman\u2019s rho 0.41 (0.23\u20130.56)], swollen joint count of 6 joints [0.47 (0.27\u20130.63)], tender enthesis count of 14 entheses [0.32 (0.12\u20130.50)] and pain score [0.28 (0.08\u20130.46)], all P\u2009&amp;lt;\u20090.05.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The proposed MRI lower-extremity inflammation index demonstrated reliability, validity, and sensitivity to change in patients with early pSpA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>Clinicaltrials.gov, http:\/\/clinicaltrials.gov, NCT01426815.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac567","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:47:52Z","timestamp":1665064072000},"page":"2130-2138","source":"Crossref","is-referenced-by-count":5,"title":["Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trial"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2877-1582","authenticated-orcid":false,"given":"Simon","family":"Krabbe","sequence":"first","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Head and Orthopaedics , Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Renson","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital , Ghent, Belgium"},{"name":"VIB Inflammation Research Center, Ghent University , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Jans","sequence":"additional","affiliation":[{"name":"Department of Radiology, Ghent University Hospital , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Elewaut","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital , Ghent, Belgium"},{"name":"VIB Inflammation Research Center, Ghent University , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van den Bosch","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital , Ghent, Belgium"},{"name":"VIB Inflammation Research Center, Ghent University , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Carron","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital , Ghent, Belgium"},{"name":"VIB Inflammation Research Center, Ghent University , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-467X","authenticated-orcid":false,"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Head and Orthopaedics , Rigshospitalet, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"2023060113243853700_keac567-B1","doi-asserted-by":"crossref","first-page":"e001136","DOI":"10.1136\/rmdopen-2019-001136","article-title":"Peripheral spondyloarthritis: a neglected entity \u2013 state of the art","volume":"6","author":"Carron","year":"2020","journal-title":"RMD Open"},{"key":"2023060113243853700_keac567-B2","doi-asserted-by":"crossref","first-page":"152012","DOI":"10.1016\/j.semarthrit.2022.152012","article-title":"What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study","volume":"55","author":"Ziade","year":"2022","journal-title":"Seminars Arthritis Rheum"},{"key":"2023060113243853700_keac567-B3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","article-title":"EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice","volume":"74","author":"Mandl","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023060113243853700_keac567-B4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/ard.2007.070243","article-title":"MRI of enthesitis of the appendicular skeleton in spondyloarthritis","volume":"66","author":"Eshed","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2023060113243853700_keac567-B5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.2007.069948","article-title":"Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis","volume":"66","author":"Althoff","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2023060113243853700_keac567-B6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejrad.2009.03.047","article-title":"Whole-body MR imaging for patients with rheumatism","volume":"70","author":"Wechback","year":"2009","journal-title":"Eur J Radiol"},{"key":"2023060113243853700_keac567-B7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejrad.2009.06.020","article-title":"Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making","volume":"77","author":"Weckbach","year":"2011","journal-title":"Eur J Radiol"},{"key":"2023060113243853700_keac567-B8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00330-013-2794-1","article-title":"Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging","volume":"23","author":"Karpitschka","year":"2013","journal-title":"Eur Radiol"},{"key":"2023060113243853700_keac567-B9","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1093\/rheumatology\/keaa153","article-title":"Novel whole-body MRI response and remission criteria document diminished inflammation during golimumab treatment in axial spondyloarthritis","volume":"59","author":"Krabbe","year":"2020","journal-title":"Rheumatology"},{"key":"2023060113243853700_keac567-B10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","article-title":"Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomized controlled trial","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2023060113243853700_keac567-B11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3899\/jrheum.150659","article-title":"Comparison of clinical examination versus whole-body magnetic resonance imaging of enthesitis in patients with early axial spondyloarthritis during 3 years of continuous etanercept treatment","volume":"43","author":"Althoff","year":"2016","journal-title":"J Rheumatol"},{"key":"2023060113243853700_keac567-B12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3899\/jrheum.170408","article-title":"Whole-body magnetic resonance imaging in axial spondyloarthritis: reduction of sacroiliac, spinal and entheseal inflammation in a placebo-controlled trial of adalimumab","volume":"45","author":"Krabbe","year":"2018","journal-title":"J Rheumatol"},{"key":"2023060113243853700_keac567-B13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3899\/jrheum.181159","article-title":"Whole-body magnetic resonance imaging inflammation in peripheral joints and entheses in axial spondyloarthritis: distribution and changes during adalimumab treatment","volume":"47","author":"Krabbe","year":"2020","journal-title":"J Rheumatol"},{"key":"2023060113243853700_keac567-B14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/annrheumdis-2016-210775","article-title":"Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study","volume":"76","author":"Carron","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023060113243853700_keac567-B15","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/art.40573","article-title":"High rate of drug-free remission after induction therapy with golimumab in early peripheral spondyloarthritis","volume":"70","author":"Carron","year":"2018","journal-title":"Arthritis Rheum"},{"key":"2023060113243853700_keac567-B16","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/art.41783","article-title":"The value of magnetic resonance imaging for assessing disease extent and prediction of relapse in early peripheral spondyloarthritis","volume":"73","author":"Renson","year":"2021","journal-title":"Arthritis Rheum"},{"key":"2023060113243853700_keac567-B17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2023060113243853700_keac567-B18","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3899\/jrheum.181093","article-title":"The OMERACT MRI in enthesitis initiative: definitions of key pathologies, suggested MRI sequences, and a novel heel enthesitis scoring system","volume":"46","author":"Mathew","year":"2019","journal-title":"J Rheumatol"},{"key":"2023060113243853700_keac567-B19","doi-asserted-by":"crossref","first-page":"e001150","DOI":"10.1136\/rmdopen-2019-001150","article-title":"Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRISS)","volume":"6","author":"Mathew","year":"2020","journal-title":"RMD Open"},{"key":"2023060113243853700_keac567-B20","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3899\/jrheum.161114","article-title":"Whole-body magnetic resonance imaging in inflammatory arthritis: systematic literature review and first steps toward standardization and an OMERACT scoring system","volume":"44","author":"\u00d8stergaard","year":"2017","journal-title":"J Rheumatol"},{"key":"2023060113243853700_keac567-B21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3899\/jrheum.181084","article-title":"Development and validation of an OMERACT MRI whole-body score for inflammation in peripheral joints and entheses in inflammatory arthritis (MRI-WIPE)","volume":"46","author":"Krabbe","year":"2019","journal-title":"J Rheumatol"},{"key":"2023060113243853700_keac567-B22","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/bioinformatics\/btl117","article-title":"Pvclust: an R package for assessing the uncertainty in hierarchical clustering","volume":"22","author":"Suzuki","year":"2006","journal-title":"Bioinformatics"},{"key":"2023060113243853700_keac567-B23","first-page":"914","article-title":"Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis","volume":"67","author":"Mease","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023060113243853700_keac567-B24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/ard.2010.145995","article-title":"Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis","volume":"70","author":"Poddubnyy","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2023060113243853700_keac567-B25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/ard.2003.018457","article-title":"Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change","volume":"64","author":"Bruynesteyn","year":"2005","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac567\/46674196\/keac567.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/6\/2130\/50500830\/keac567.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/6\/2130\/50500830\/keac567.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T13:35:51Z","timestamp":1685626551000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/6\/2130\/6749600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,10,6]]},"published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac567","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2022,10,6]]}}}